Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation.

Dalton WB, Helmenstine E, Walsh N, Gondek LP, Kelkar DS, Read A, Natrajan R, Christenson ES, Roman B, Das S, Zhao L, Leone RD, Shinn D, Groginski T, Madugundu AK, Patil A, Zabransky DJ, Medford A, Lee J, Cole AJ, Rosen M, Thakar M, Ambinder A, Donaldson J, DeZern AE, Cravero K, Chu D, Madero-Marroquin R, Pandey A, Hurley PJ, Lauring J, Park BH.

J Clin Invest. 2019 Aug 8;130. pii: 125022. doi: 10.1172/JCI125022.

2.

Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction.

Hambley BC, Norsworthy KJ, Jasem J, Zimmerman JW, Shenderov E, Webster JA, Showel MM, Gondek LP, Dalton WB, Prince G, Gladstone DE, Streiff MB, Pratz KW, Gojo I, Ghiaur G, Levis MJ, Smith BD, DeZern AE.

Leuk Res. 2019 Aug;83:106174. doi: 10.1016/j.leukres.2019.106174. Epub 2019 Jun 21. No abstract available.

PMID:
31255938
3.

The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies.

Button B, Croessmann S, Chu D, Rosen DM, Zabransky DJ, Dalton WB, Cravero K, Kyker-Snowman K, Waters I, Karthikeyan S, Christenson ES, Donaldson J, Hunter T, Dennison L, Ramin C, May B, Roden R, Petry D, Armstrong DK, Visvanathan K, Park BH.

Breast Cancer Res Treat. 2019 Apr;174(2):401-412. doi: 10.1007/s10549-018-05087-7. Epub 2018 Dec 17.

PMID:
30560461
4.

Single-Nucleotide Polymorphism Leading to False Allelic Fraction by Droplet Digital PCR.

Christenson ES, Dalton WB, Chu D, Waters I, Cravero K, Zabransky DJ, DeZern AE, Park BH.

Clin Chem. 2017 Aug;63(8):1370-1376. doi: 10.1373/clinchem.2017.273177. Epub 2017 Jun 14.

5.

PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity.

Croessmann S, Wong HY, Zabransky DJ, Chu D, Rosen DM, Cidado J, Cochran RL, Dalton WB, Erlanger B, Cravero K, Button B, Kyker-Snowman K, Hurley PJ, Lauring J, Park BH.

Breast Cancer Res Treat. 2017 Apr;162(3):451-464. doi: 10.1007/s10549-017-4147-2. Epub 2017 Feb 11.

6.

Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board.

Dalton WB, Forde PM, Kang H, Connolly RM, Stearns V, Gocke CD, Eshleman JR, Axilbund J, Petry D, Geoghegan C, Wolff AC, Loeb DM, Pratilas CA, Meyer CF, Christenson ES, Slater SA, Ensminger J, Parsons HA, Park BH, Lauring J.

JCO Precis Oncol. 2017;2017. doi: 10.1200/PO.16.00046. Epub 2017 May 31.

7.

A Polycythemia Vera JAK2 Mutation Masquerading as a Duodenal Cancer Mutation.

Lee J, Axilbund J, Dalton WB, Laheru D, Watkins S, Chu D, Cravero K, Button B, Kyker-Snowman K, Waters I, Gocke CD, Lauring J, Park BH.

J Natl Compr Canc Netw. 2016 Dec;14(12):1495-1498.

PMID:
27956534
8.

HER2 missense mutations have distinct effects on oncogenic signaling and migration.

Zabransky DJ, Yankaskas CL, Cochran RL, Wong HY, Croessmann S, Chu D, Kavuri SM, Red Brewer M, Rosen DM, Dalton WB, Cimino-Mathews A, Cravero K, Button B, Kyker-Snowman K, Cidado J, Erlanger B, Parsons HA, Manto KM, Bose R, Lauring J, Arteaga CL, Konstantopoulos K, Park BH.

Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):E6205-14. doi: 10.1073/pnas.1516853112. Epub 2015 Oct 27.

9.

NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability.

Croessmann S, Wong HY, Zabransky DJ, Chu D, Mendonca J, Sharma A, Mohseni M, Rosen DM, Scharpf RB, Cidado J, Cochran RL, Parsons HA, Dalton WB, Erlanger B, Button B, Cravero K, Kyker-Snowman K, Beaver JA, Kachhap S, Hurley PJ, Lauring J, Park BH.

Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11583-8. doi: 10.1073/pnas.1503683112. Epub 2015 Aug 31.

10.

ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients.

Chu D, Paoletti C, Gersch C, VanDenBerg DA, Zabransky DJ, Cochran RL, Wong HY, Toro PV, Cidado J, Croessmann S, Erlanger B, Cravero K, Kyker-Snowman K, Button B, Parsons HA, Dalton WB, Gillani R, Medford A, Aung K, Tokudome N, Chinnaiyan AM, Schott A, Robinson D, Jacks KS, Lauring J, Hurley PJ, Hayes DF, Rae JM, Park BH.

Clin Cancer Res. 2016 Feb 15;22(4):993-9. doi: 10.1158/1078-0432.CCR-15-0943. Epub 2015 Aug 10.

11.

CDK1 regulates mediator of DNA damage checkpoint 1 during mitotic DNA damage.

Yu B, Dalton WB, Yang VW.

Cancer Res. 2012 Nov 1;72(21):5448-53. doi: 10.1158/0008-5472.CAN-12-2354. Epub 2012 Sep 7.

12.

A novel microtubule-modulating noscapinoid triggers apoptosis by inducing spindle multipolarity via centrosome amplification and declustering.

Karna P, Rida PC, Pannu V, Gupta KK, Dalton WB, Joshi H, Yang VW, Zhou J, Aneja R.

Cell Death Differ. 2011 Apr;18(4):632-44. doi: 10.1038/cdd.2010.133. Epub 2010 Nov 5.

13.

p53 suppresses structural chromosome instability after mitotic arrest in human cells.

Dalton WB, Yu B, Yang VW.

Oncogene. 2010 Apr 1;29(13):1929-40. doi: 10.1038/onc.2009.477. Epub 2010 Jan 11.

14.

Role of prolonged mitotic checkpoint activation in the formation and treatment of cancer.

Dalton WB, Yang VW.

Future Oncol. 2009 Nov;5(9):1363-70. doi: 10.2217/fon.09.118. Review.

15.

Mouse embryonic fibroblasts null for the Krüppel-like factor 4 gene are genetically unstable.

Hagos EG, Ghaleb AM, Dalton WB, Bialkowska AB, Yang VW.

Oncogene. 2009 Mar 5;28(9):1197-205. doi: 10.1038/onc.2008.465. Epub 2009 Jan 12.

16.

Mitotic Origins of Chromosomal Instability in Colorectal Cancer.

Dalton WB, Yang VW.

Curr Colorectal Cancer Rep. 2007 Apr;3(2):59-64.

17.

Human cancer cells commonly acquire DNA damage during mitotic arrest.

Dalton WB, Nandan MO, Moore RT, Yang VW.

Cancer Res. 2007 Dec 15;67(24):11487-92.

18.

Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells.

Liu P, Ramachandran S, Ali Seyed M, Scharer CD, Laycock N, Dalton WB, Williams H, Karanam S, Datta MW, Jaye DL, Moreno CS.

Cancer Res. 2006 Apr 15;66(8):4011-9.

19.
20.

Krüppel-like factor 4 prevents centrosome amplification following gamma-irradiation-induced DNA damage.

Yoon HS, Ghaleb AM, Nandan MO, Hisamuddin IM, Dalton WB, Yang VW.

Oncogene. 2005 Jun 9;24(25):4017-25.

21.

Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation.

Ghaleb AM, Nandan MO, Chanchevalap S, Dalton WB, Hisamuddin IM, Yang VW.

Cell Res. 2005 Feb;15(2):92-6. Review.

22.

Quetiapine as treatment for dopaminergic-induced dyskinesias in Parkinson's disease.

Baron MS, Dalton WB.

Mov Disord. 2003 Oct;18(10):1208-9. No abstract available.

PMID:
14534933

Supplemental Content

Loading ...
Support Center